Course Overview
This Ausmed Course will provide an overview of the impact a high BMI has upon community health, pregnancy, labour, birth and breastfeeding.
Topics
- What is the link between high BMI, insulin resistance, androgenisation and PCOS?
- What are the effects of high BMI on efficient labour?
- How can you engage women with a high BMI through education and appropriate interventions?
Need
Numerous studies have demonstrated the adverse effects of obesity on the reproductive process, with evidence linking preconception maternal obesity and long-term disease in offspring. Maternal obesity is also linked to higher rates of caesarean section, as well as high-risk obstetrical conditions such as diabetes and hypertension.
Additionally, a high body mass index (BMI) during the reproductive process adversely affects pregnancy outcomes, such as increasing the risk of neonatal mortality and malformations.
As midwives and nurses are likely to care for women of reproductive age they must be aware of and educate about the potential adverse effects a high BMI can have on health, conception and pregnancy.
Purpose
The purpose of this Ausmed Course is to review the potential adverse effects high maternal BMI has upon reproduction, in order to ensure learners are able to educate their patients accordingly to achieve positive health outcomes.
Learning Outcomes
- Intervene in weight management early by identifying the different classes of obesity through effective assessment of women with high BMIs.
- Use knowledge of the link between high BMI and reproductive problems to appropriately manage obese women throughout their pregnancy.
- Correlate potential adverse pregnancy and labour outcomes with strategies to educate women about the impact obesity may have on their pregnancy.
Target Audience
This Ausmed Course is most relevant to registered midwives, nurses and lactation consultants working with women throughout their reproductive years, especially during the perinatal period.
Disclosure
No conflict of interest exists for anyone in the position to control content for this activity. Wherever possible, generic or non-proprietary names of medications or products have been used.